Food for thoughtJP Morgan recently had their big healthcare conference and TH utilized that to have meetings with analysts, bankers and potential partners. JPM recently picked up coverage of BGNE with a 65 page report. Paul reported to shareholders he was meeting with that TH had a growing relationship with JPM and a JPM banker did something (I can't remember exactly what) on TH's LinkedIn site. TH wished people a Happy Chinese New Year for the first time ever on their LinkedIn site and Paul is following BGNE on LinkedIn. JPM was one of the underwriters of BGNE's recent offering on 12/15/21.
Could there be something more signinficant on the horizon than just a partership between BGNE and TH? Probably not but there are signs that a lot of talking is going on among these three entities and once you start talking you never know where it might lead. You know JPM would be keen to get something going where they earn a nice fee. TH could sell a stake in TH to BGNE to fund NASH and/or finance the potential redemption of the convert?
There is likely nothing there but where there is smoke there has to be a fire.